Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
29.87
-0.75 (-2.45%)
Apr 21, 2026, 3:10 PM CST
Staidson (Beijing) BioPharmaceuticals Employees
Staidson (Beijing) BioPharmaceuticals had 484 employees as of June 30, 2025. The number of employees decreased by 8 or -1.63% since the number was reported on December 31, 2024.
Employees
484
Change
-8
Growth
-1.63%
Revenue / Employee
496.68K CNY
Profits / Employee
-337.74K CNY
Market Cap
14.27B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 484 | -8 | -1.63% |
| Dec 31, 2024 | 492 | -63 | -11.35% |
| Dec 31, 2023 | 555 | -248 | -30.88% |
| Jan 1, 2023 | 803 | -70 | -8.02% |
| Dec 31, 2021 | 873 | 38 | 4.55% |
| Dec 31, 2020 | 835 | -31 | -3.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,295 |
| Tibet Cheezheng Tibetan Medicine | 3,170 |
| Pacific Shuanglin Bio-pharmacy | 2,635 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Vcanbio Cell & Gene Engineering Corp., | 2,014 |
| Jinyu Bio-technology | 1,740 |
| Mabwell (Shanghai) Bioscience | 1,325 |
| Inner Mongolia Furui Medical Science | 946 |